The Effectiveness and Feasibility of Using Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test.
Phase of Trial: Phase IV
Latest Information Update: 29 Oct 2015
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 26 Oct 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2018, according to ClinicalTrials.gov record.
- 26 Oct 2015 Planned primary completion date changed to 1 Dec 2017, according to ClinicalTrials.gov record.
- 26 Oct 2015 Status changed from active, no longer recruiting to recruiting, according to ClinicalTrials.gov record.